SEC Company Response from BIOMARIN PHARMACEUTICAL INC (BMRN) (CIK 0001048477) (BMRN) — Jan 3, 2008
BIOMARIN PHARMACEUTICAL INC (BMRN) (CIK 0001048477)
Date: Jan. 3, 2008 · CIK: 0001048477 · Accession: 0001193125-08-000912
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 000-26727
Referenced dates: December 20, 2007
Letter
Via EDGAR and Facsimile Securities and Exchange Commission Re: BioMarin Pharmaceutical Inc. Form 10-K for the Fiscal Year Ended December 30, 2006 Form 10-Q for the Quarterly Period Ended September 30, 2007 File No. 000-26727
Dear Mr. Rosenberg:
We are writing to request a ten (10) business day extension to respond to comments received from the Staff of the Securities and Exchange Commission (the “Staff”), by letter dated December 20, 2007 (the “Comment Letter”), with respect to BioMarin Pharmaceutical Inc.’s (the “Company”) Form 10-K for the fiscal year ended December 30, 2006 and Form 10-Q for the quarterly period ended September 30, 2007. Due to the Company shutdown during the Christmas and New Year’s holidays, the Company respectfully requests an extension through January 16, 2008 to respond to the Comment Letter.
We appreciate the Staff’s courtesy and cooperation in this process. If you have any questions, please contact me by telephone at (415) 506-6307.
Very Truly Yours,
/s/ G. Eric Davis
Show Raw Text
CORRESP 1 filename1.htm Correspondence Letter January 3, 2008 Via EDGAR and Facsimile Mr. Jim B. Rosenberg Senior Assistant Chief Accountant Securities and Exchange Commission 100 F Street, NE Washington, D.C. 20549-6010 Re: BioMarin Pharmaceutical Inc. Form 10-K for the Fiscal Year Ended December 30, 2006 Form 10-Q for the Quarterly Period Ended September 30, 2007 File No. 000-26727 Dear Mr. Rosenberg: We are writing to request a ten (10) business day extension to respond to comments received from the Staff of the Securities and Exchange Commission (the “Staff”), by letter dated December 20, 2007 (the “Comment Letter”), with respect to BioMarin Pharmaceutical Inc.’s (the “Company”) Form 10-K for the fiscal year ended December 30, 2006 and Form 10-Q for the quarterly period ended September 30, 2007. Due to the Company shutdown during the Christmas and New Year’s holidays, the Company respectfully requests an extension through January 16, 2008 to respond to the Comment Letter. We appreciate the Staff’s courtesy and cooperation in this process. If you have any questions, please contact me by telephone at (415) 506-6307. Very Truly Yours, /s/ G. Eric Davis G. Eric Davis Vice President, General Counsel and Secretary